OTHER GROUP COMPANIES
market

Bafna Pharma gets Renewal Certificate from MHRA, London

The stock of the company is up by 12% at Rs. 27.70.

June 10, 2015 10:21 IST | India Infoline News Service
Doctor prescription and medicine
With reference to the earlier intimation on March 02, 2015 about the successful completion of MHRA audit process, Bafna Pharmaceuticals Ltd has now informed BSE that the Company got the RENEWAL certificate from MHRA, London.
The stock of the company is up by 12% at Rs. 27.70.
It has hit a high of Rs. 29.40 and low of Rs. 25.25.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity